Literature DB >> 6459816

Ornithine aminotransferase in Huntington's disease.

P T Wong, P L McGeer, M Rossor, E G McGeer.   

Abstract

Ornithine aminotransferase (Orn-T) activities in Huntington's disease (HD) brains were found to be reduced, when compared to age-matched control brains, by 34-49% in the frontal cortex, parietal cortex, caudate nucleus and putamen. Such changes were not observed in senile dementia of Alzheimer type or schizophrenia. Alterations in choline acetyltransferase activities were consistent with previous findings for these disorders. If Orn-T is involved in the synthesis of neurotransmitter glutamate, the reported losses of Orn-T activity may reflect deterioration of the corticostriatal glutamatergic neurons in HD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6459816     DOI: 10.1016/0006-8993(82)90385-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  The corticostriatal pathway in Huntington's disease.

Authors:  Carlos Cepeda; Nanping Wu; Véronique M André; Damian M Cummings; Michael S Levine
Journal:  Prog Neurobiol       Date:  2006-12-13       Impact factor: 11.685

Review 2.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

Review 3.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07

Review 4.  Roles of the Neuron-Restrictive Silencer Factor in the Pathophysiological Process of the Central Nervous System.

Authors:  Xin-Jin Su; Bei-Duo Shen; Kun Wang; Qing-Xin Song; Xue Yang; De-Sheng Wu; Hong-Xing Shen; Chao Zhu
Journal:  Front Cell Dev Biol       Date:  2022-03-01

5.  Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.

Authors:  Chiara Zuccato; Nikolai Belyaev; Paola Conforti; Lezanne Ooi; Marzia Tartari; Evangelia Papadimou; Marcy MacDonald; Elisa Fossale; Scott Zeitlin; Noel Buckley; Elena Cattaneo
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

Review 6.  Corticostriatal Dysfunction in Huntington's Disease: The Basics.

Authors:  Kendra D Bunner; George V Rebec
Journal:  Front Hum Neurosci       Date:  2016-06-28       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.